Comparing apples and oranges: considerations for quantifying candidal biofilms with XTT [2,3-bis(2-methoxy-4-nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxanilide] and the need for standardized testing

Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection—Scotland, 2012–2013

(2016) R. Rajendran et al.   CLINICAL MICROBIOLOGY AND INFECTION

In vitro biofilm production of Candida bloodstream isolates: any association with clinical characteristics?

(2016) Júlia Pongrácz et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Production of biofilm by Candida and non-Candida spp. isolates causing fungemia: Comparison of biomass production and metabolic activity and development of cut-off points

(2014) Laura Judith Marcos-Zambrano et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing

(2014) Christopher G Pierce et al.   Nature Protocols

Risk Factors and Outcomes of Candidemia Caused by Biofilm-Forming Isolates in a Tertiary Care Hospital

(2012) Mario Tumbarello et al.   PLoS One

Comparative analysis ofCandidabiofilm quantitation assays

(2011) Heather T. Taff et al.   MEDICAL MYCOLOGY